Literature DB >> 6182253

Preliminary characterization of equine interferons and their antiviral activities on bovine, ovine, and human cells.

T Yilma, T C McGuire, L E Perryman.   

Abstract

Equine dermal cells induced with poly I:C + DEAE-dextran produced low levels of interferon tentatively classified as equine interferon beta (EqIFN-beta). In contrast, dermal cells initially primed with EqIFN-beta and then superinduced with poly I:C + DEAE-dextran in the presence of cycloheximide and actinomycin D produced greater than 100-fold EqIFN-beta. Equine blood mononuclear cells induced with Newcastle disease virus and phytohemagglutinin produced high levels of interferons tentatively classified as equine interferon alpha (EqIFN-alpha) and equine interferon gamma (EqIFN-gamma), respectively. Both EqIFN-beta and EqIFN-gamma exhibited equivalent antiviral activity on equine, bovine, and ovine cells while EqIFN-alpha had greater activity on bovine and ovine cells than on equine cells. Furthermore, EqIFN-alpha had high antiviral activity on human cells. No detectable levels of antiviral activity of equine interferons was observed on feline and mouse cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182253     DOI: 10.1089/jir.1982.2.363

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  4 in total

1.  Temporary suppression of cell-mediated immunity in standardbred horses with decreased athletic capacity.

Authors:  M Jensen-Waern; S G Persson; A Nordengrahn; M Mérza; C Fossum
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

2.  Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.

Authors:  James F Papin; Paulo H Verardi; Leslie A Jones; Francisco Monge-Navarro; Aaron C Brault; Michael R Holbrook; Melissa N Worthy; Alexander N Freiberg; Tilahun D Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-23       Impact factor: 11.205

3.  Genomic analysis and mRNA expression of equine type I interferon genes.

Authors:  Olivier Detournay; David A Morrison; Bettina Wagner; Behdad Zarnegar; Eva Wattrang
Journal:  J Interferon Cytokine Res       Date:  2013-06-17       Impact factor: 2.607

4.  Innate immunity during Equid herpesvirus 1 (EHV-1) infection.

Authors:  C G Bridges; N Edington
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.